What is the best-rated treatment for fatty liver?

Ratings appear as FDA recall-safety data accumulates for the products that may treat fatty liver.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat fatty liver?

Treatments for fatty liver span FDA drug classes including thyroid hormone receptor beta agonist. Compare every option side by side, ranked by independent rating, above.

Best treatments for fatty liver

1 product may treat fatty liver, spanning FDA drug classes such as thyroid hormone receptor beta agonist. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Understanding fatty liver

Fatty liver disease — now called steatotic liver disease — happens when too much fat builds up in your liver. There are two main types: metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called NAFLD, which is not caused by heavy alcohol use, and alcohol-associated liver disease (ALD). In MASLD, simple fatty liver means fat with little or no inflammation or liver damage. MASH adds inflammation and liver damage, which can scar the liver and sometimes lead to cirrhosis or liver cancer. Both MASLD and ALD usually have few or no symptoms; if symptoms do appear, you may feel tired or have discomfort in the upper right side of your abdomen. It is often suspected after abnormal results on liver tests. Diagnosis relies on your medical history, a physical exam, blood tests and imaging. Raised ALT and AST liver enzymes are a common clue, and routine results can be used to calculate fibrosis scores such as FIB-4. Ultrasound, CT or MRI can show liver fat; elastography measures liver stiffness to look for advanced fibrosis. Liver biopsy is the only test that can prove MASH, and doctors do not recommend it for everyone. It is common: NIDDK estimates about 24% of U.S. adults have NAFLD/MASLD. Risk is higher in people with type 2 diabetes or prediabetes, obesity, high cholesterol or triglycerides, and high blood pressure. This page is general information, not medical advice.

First-line treatment

The American Gastroenterological Association's clinical care pathway for MASLD, published March 2026, organizes care around how much liver scarring (fibrosis) is present: fibrosis is the key predictor of outcomes, with clinically significant risk beginning at stage 2. Screening focuses on three high-risk groups — adults with type 2 diabetes, people who are overweight or obese with at least one additional metabolic risk factor, and those with incidental liver steatosis on imaging or elevated liver enzymes. The simple FIB-4 score comes first; liver stiffness measurement or a specialized blood test confirms risk, and higher values should prompt referral to hepatology. For everyone with MASLD, lifestyle and cardiometabolic risk management come first: a Mediterranean diet, regular physical activity, limiting alcohol, and achieving 5–10% weight loss. NIDDK adds that losing at least 3% to 5% of body weight can reduce liver fat, and that physical activity alone, even without weight loss, is beneficial. Where medication is considered — weight- and diabetes-directed therapies, or liver-directed therapy for F2–F3 fibrosis — the pathway calls for individualized treatment decisions, made by a clinician for each patient.

Full ranking · 1 treatments

rezdiffra

PrescriptionFDA-sourced

New

Rezdiffra (Resmetirom) is a thyroid hormone receptor beta agonist used to treat Fatty Liver, Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease.

thyroid hormone receptor beta agonistfatty liverliver cirrhosis

Price varies

View details →

Frequently asked

What treats fatty liver?: Our catalog lists 1 product that may treat fatty liver, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
What is the best-rated treatment for fatty liver?: Ratings appear as FDA recall-safety data accumulates for the products that may treat fatty liver.
How are these treatments ranked?: By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat fatty liver?: Treatments for fatty liver span FDA drug classes including thyroid hormone receptor beta agonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.

Sources

The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.